International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 4 , Pages 1021-1028 , 15 November 2009

Ductal Carcinoma In Situ of the Breast With Close or Focally Involved Margins Following Breast-Conserving Surgery: Treatment With Reexcision or Radiotherapy With Increased Dosage

  • Amélie Monteau, M.D.

      Affiliations

    • Department of Radiation Oncology, Institut Curie, Paris, France
    • ,
  • Brigitte Sigal-Zafrani, M.D.

      Affiliations

    • Department of Pathology, Institut Curie, Paris, France
    • ,
  • Youlia M. Kirova, M.D.

      Affiliations

    • Department of Radiation Oncology, Institut Curie, Paris, France
    • ,
  • Virginie Fourchotte, M.D.

      Affiliations

    • Department of Surgery, Institut Curie, Paris, France
    • ,
  • Marc A. Bollet, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Institut Curie, Paris, France
    • ,
  • Anne Vincent-Salomon, M.D., Ph.D.

      Affiliations

    • Department of Pathology, Institut Curie, Paris, France
    • ,
  • Bernard Asselain, M.D.

      Affiliations

    • Department of Biostatistics, Institut Curie, Paris, France
    • ,
  • Remy J. Salmon, M.D.

      Affiliations

    • Department of Surgery, Institut Curie, Paris, France
    • ,
  • Alain Fourquet, M.D.

      Affiliations

    • Department of Radiation Oncology, Institut Curie, Paris, France
    • Corresponding Author InformationReprint requests to: Alain Fourquet, M.D., Department of Radiation Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Tel: (+33) 1 44 32 46 31; Fax: (+33) 1 53 10 26 53

Received 7 October 2008 ,Revised 29 November 2008 ,Accepted 2 December 2008.

References 

  1. Ernster VL, Barclay J, Kerlikowske K, et al. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160:953–958
  2. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized Phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24:3381–3387
  3. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience. Semin Oncol. 2001;28:400–418
  4. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26:1247–12452
  5. Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet. 2003;362:95–102
  6. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2005;103:1137–1146
  7. Kestin LL, Goldstein NS, Lacerna MD, et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer. 2000;88:596–607
  8. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: The French Cancer Centers' experience. Int J Radiat Oncol Biol Phys. 2002;53:868–879
  9. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: A critical review of the literature. J Clin Oncol. 2002;20:2736–2744
  10. Vargas C, Kestin L, Go N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005;63:1514–1521
  11. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:279–287
  12. The American College of Surgeons. Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS). J Am Coll Surg. 2007;205:145–161
  13. Olivotto I, Levine M. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). CMAJ. 2001;165:912–913
  14. Cutuli B, Fourquet A, Luporsi E, et al. [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. Bull Cancer. 2005;92:155–168
  15. Luini A, Rososchansky J, Gatti G, et al. The surgical margin status after breast-conserving surgery: Discussion of an open issue (Epub ahead of print April 4, 2008). Breast Cancer Res Treat.
  16. Jones HA, Antonini N, Collette L, et al. The impact of boost dose and margins on the local recurrence rate in breast conserving therapy: Results from the EORTC Boost-No Boost Trial. Proceedings of the ASTRO's 49th Annual Meeting; 2007 Oct 28–Nov 1; Los Angeles, CA. Int J Radiat Oncol Biol Phys. 2007;69(Suppl. 1):S2–S3
  17. Sigal-Zafrani B, Lewis JS, Clough KB, et al. Histological margin assessment for breast ductal carcinoma in situ: Precision and implications. Mod Pathol. 2004;17:81–88
  18. The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer. 1997;80:1798–1802
  19. Fourquet A, Campana F, Rosenwald JC, Vilcoq JR. Breast irradiation in the lateral decubitus position: Technique of the Institut Curie. Radiother Oncol. 1991;22:261–265
  20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  21. Cox DR. Regression models and life-tables. J Royal Stat Soc Series B. 1972;34:187–220
  22. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: Intraductal carcinoma. Cancer. 1999;86:429–438
  23. Omlin A, Amichetti M, Azria D, et al. Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol. 2006;7:652–656
  24. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259–3265
  25. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963–968
  26. Vincent-Salomon A, Lucchesi C, Gruel N, et al. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin Cancer Res. 2008;14:1956–1965
  27. Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 1993;218:22–28
  28. Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys. 2003;57:724–731
  29. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 1998;40:851–858
  30. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–1675
  31. DiBiase SJ, Komarnicky LT, Heron DE, et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phy. 2002;53:680–686
  32. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer. 2002;94:1917–1924
  33. Dillon MF, Mc Dermott EW, O'Doherty A, et al. Factors affecting successful breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2007;14:1618–1628
  34. Fourquet A, Sigal-Zafrani B, Clough KB. Breast-conserving surgery plus radiation therapy in ductal carcinoma in situ: The Institut Curie experience. In:  Silverstein MJ,  Recht A,  Lagios MD editor. Ductal carcinoma in situ of the breast. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002;p. 367–372

 Presented at the 6th European Breast Cancer Conference (EBCC), Berlin, April 2008.

 Conflict of interest: none.

PII: S0360-3016(08)03827-3

doi: 10.1016/j.ijrobp.2008.12.014

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 4 , Pages 1021-1028 , 15 November 2009

Article Tools

* Image Usage & Resolution